{"meshTags":["Adenocarcinoma","Animals","Antineoplastic Agents","Lung Neoplasms","NF-kappa B"],"meshMinor":["Adenocarcinoma","Animals","Antineoplastic Agents","Lung Neoplasms","NF-kappa B"],"genes":["NF-κB","inhibitor-κB kinase","NF-κB","Kras","p53"],"organisms":["10090","10090"],"publicationTypes":["Comment","Journal Article"],"abstract":"Xue et al. demonstrate response and increased survival but development of acquired resistance to proteasome and inhibitor-κB kinase inhibitors targeting NF-κB activation in adenocarcinomas of Kras-activated, p53-deficient mice.","title":"Targeting NF-κB in mouse models of lung adenocarcinoma.","pubmedId":"22586569"}